[Federal Register Volume 79, Number 241 (Tuesday, December 16, 2014)]
[Notices]
[Pages 74724-74725]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-29291]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30-Day 15-0910]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

    Message Testing for Tobacco Communication Activities (OMB No. 0920-
0910, exp. 1/31/2015)--Revision--National Center for Chronic Disease 
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control 
and Prevention (CDC).

Background and Brief Description

    In 2012, CDC's Office on Smoking and Health obtained OMB approval 
of a generic clearance to support the development and testing of 
tobacco-related health messages, including messages disseminated 
through multiple phases of an ACA-funded media campaign (Message 
Testing for Tobacco Communication Activities (MTTCA), OMB No. 0920-
0910, exp. 1/31/2015). CDC has employed the MTTCA clearance to collect 
information about adult smokers' and nonsmokers' attitudes and 
perceptions, and to pre-test draft messages and materials for clarity, 
salience, appeal, and persuasiveness. Information collection modes that 
are supported include in-depth interviews, in-person focus groups, 
online focus groups, computer-assisted, in-person, or telephone 
interviews, and online surveys. Messages have been developed for 
multiple media channels including television, radio, print, and digital 
formats.
    CDC requests OMB approval to extend the MTTCA clearance, with 
changes, for three years. The Revision information collection request 
will propose a 20% increase in the annualized estimated number of 
respondents (from 36,847 to 44,216) and a 52% increase in the 
annualized estimated burden hours (from 7,219 to 10,998). The increases 
will be used for short, medium and in-depth surveys which are in line 
with activities proposed in the initial generic clearance. These 
increases are needed to support CDC's planned information collections 
and to accommodate additional needs that CDC may identify during the 
next three years. For example, the MTTCA generic clearance may be used 
to facilitate the development of tobacco-related health communications 
of interest for CDC's collaborative efforts with other federal partners 
including, but not limited to, the Food and Drug Administration (FDA), 
the Substance Abuse and Mental Health Services Administration (SAMHSA), 
the National Institutes of Health (NIH), and the National Cancer 
Institute (NCI). At this time the revised MTTCA clearance is expected 
to be sufficient to test tobacco related messages developed by CDC for 
the

[[Page 74725]]

general US population and subpopulations of interest. The MTTCA 
clearance should not replace the need for additional generic clearance 
mechanisms of HHS and other federal partners that may need to test 
tobacco messages related to their campaigns and initiatives.
    CDC's revised MTTCA clearance also describes expansion of the 
target audience(s) that may be involved in message testing, such as 
youth ages 13-17 years. Media campaigns have been shown to be effective 
as part of a comprehensive tobacco control program to decrease the 
initiation of tobacco use among youths and young adults.
    Finally, there may be a need to test prevention and cessation 
messages related to products that are not currently regulated, 
including non-combustible tobacco products (electronic nicotine 
delivery systems such as electronic cigarettes or e-cigarettes) and 
some combustible products (such as cigars/little cigars and 
cigarillos). In the event that the FDA receives authority to regulate 
these products and decides to do a campaign about them, CDC will 
continue to work closely with FDA to avoid duplication. Additionally, 
CDC will share with FDA the findings from any formative work related to 
the youth audience.
    CDC will continue to use the MTTCA clearance to develop and test 
messages and materials. Participation is voluntary and there are no 
costs to respondents other than their time. The total estimated 
annualized burden hours are 10,998.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
        Type of respondents                   Form name              Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
General Public and Special           Screening and Recruitment..          20,000               1            2/60
 Populations.                        In-depth Interviews (In                  96               1               1
                                      Person, telephone, etc.).
                                     Focus Groups (In Person)...             160               1           90/60
                                     Focus Groups (Online)......             120               1               1
                                     Short Surveys/information             9,800               1           10/60
                                      needed to screen
                                      individuals being
                                      considered for inclusion
                                      in campaign ads (Online,
                                      Bulletin Board, etc.).
                                     Medium Surveys (Online)....           9,940               1           25/60
                                     In-depth Surveys (Online)..           4,100               1               1
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-29291 Filed 12-15-14; 8:45 am]
BILLING CODE 4163-18-P